Tenon Medical Inc TNON.OQ TNON.O is expected to show a rise in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025
The Los Gatos California-based company is expected to report a 66.7% increase in revenue to $1.199 million from $719 thousand a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Tenon Medical Inc is for a loss of $1.11 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Tenon Medical Inc is $3.00, above its last closing price of $1.11.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-2.54
-2.54
Met
0
Sep. 30 2024
-4.05
-4.23
-3.63
Beat
14.3
Jun. 30 2024
-8.72
-8.68
-8.16
Beat
6
Mar. 31 2024
-10.72
-10.72
-10.00
Beat
6.7
Dec. 31 2023
-11.04
-11.04
-5.44
Beat
50.7
Sep. 30 2023
-21.90
-22.40
-11.68
Beat
47.9
Jun. 30 2023
-30.40
-30.40
-26.40
Beat
13.2
Mar. 31 2023
-29.60
-34.40
Missed
-16.2
This summary was machine generated May 9 at 21:27 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)